Survival analysis according to CEBPA and GATA2 mutational status within the cohort of 4461 patients receiving intensive treatment. Kaplan-Meier plots showing OS (A) and EFS (B) of CEBPA^wt, compared with CEBPA^bi/GATA2^wt (n = 82), CEBPA^bi/GATA2^mut (n = 46), CEBPA^smbZIP/GATA2^wt(n = 31), CEBPA^smbZIP/GATA2^mut (n = 18) mutant cases. Survival analysis according to CEBPA mutation status and TET2 status within a cohort of 4461 patients. Kaplan-Meier plots showing OS (C) and EFS (D) of CEBPA^wt, compared with CEBPA^bi/TET2^wt (n = 98), CEBPA^bi/TET2^mut (n = 30), CEBPA^smbZIP/TET2^wt (n = 33), CEBPA^smbZIP/TET2^mut (n = 16) mutant cases. Numbers of patients at risk and results of log-rank tests from pairwise comparisons are provided below the x-axis.